Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$244K Hold
10,150
0.17% 124
2026
Q1
$285K Buy
+10,150
New +$270K 0.21% 119
2025
Q2
Sell
-7,900
Closed -$200K 134
2025
Q1
$200K Sell
7,900
-6,200
-44% -$162K 0.26% 90
2024
Q4
$374K Buy
14,100
+5,670
+67% +$154K 0.3% 95
2024
Q3
$244K Buy
8,430
+1,250
+17% +$36.5K 0.2% 119
2024
Q2
$201K Sell
7,180
-442
-6% -$12.2K 0.17% 120
2024
Q1
$212K Sell
7,622
-4,028
-35% -$112K 0.19% 112
2023
Q4
$335K Sell
11,650
-738
-6% -$22.3K 0.3% 95
2023
Q3
$411K Sell
12,388
-1,365
-10% -$48.3K 0.4% 78
2023
Q2
$504K Sell
13,753
-875
-6% -$34.1K 0.47% 74
2023
Q1
$597K Sell
14,628
-1,052
-7% -$45.4K 0.57% 63
2022
Q4
$803K Sell
15,680
-40
-0.3% -$1.92K 0.75% 44
2022
Q3
$688K Sell
15,720
-1,330
-8% -$64.6K 0.68% 52
2022
Q2
$894K Sell
17,050
-265
-2% -$13.5K 0.79% 42
2022
Q1
$896K Sell
17,315
-6,937
-29% -$360K 0.65% 55
2021
Q4
$1.43M Buy
24,252
+100
+0.4% +$4.96K 0.95% 31
2021
Q3
$1.04M Buy
24,152
+300
+1% +$13.3K 0.76% 45
2021
Q2
$934K Hold
23,852
0.68% 52
2021
Q1
$864K Buy
23,852
+130
+0.5% +$4.62K 0.68% 48
2020
Q4
$873K Buy
23,722
+911
+4% +$33.4K 0.73% 43
2020
Q3
$794K Buy
22,811
+1,358
+6% +$47.6K 0.82% 41
2020
Q2
$666K Buy
21,453
+2,266
+12% +$77K 0.76% 42
2020
Q1
$594K Sell
19,187
-1,038
-5% -$35.4K 0.81% 42
2019
Q4
$752K Buy
+20,225
New +$720K 0.76% 40

Other funds holding PFE

Bank of Marin's PFE Position: Q2 2026 in Review

Bank of Marin held its Pfizer (PFE) position steady in Q2 2026 at 10,150 shares worth $244K. The position accounts for 0.17% of the portfolio, ranked #124.

Bank of Marin first reported a position in PFE in Q4 2019 and has held it in 24 quarters since. The position peaked at $1.43M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bank of Marin held 10,150 shares of Pfizer worth $244K as of Q2 2026.
  • Bank of Marin left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.17% of Bank of Marin's portfolio in Q2 2026, its #124 holding.
  • Bank of Marin first reported a position in Pfizer in Q4 2019 and has held it in 24 quarters since.
  • Bank of Marin's Pfizer position peaked at $1.43M in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bank of Marin's 13F filing for Q2 2026, filed 13 Aug 2026.